Find the right fit for you - faster
Get tailored insights about working at Systimmune in one quick step.
Systimmune Snapshot
SystImmune Inc., is a wholly owned and subsidiary of a pharmaceutical company and funded by venture capital firm OrbiMed. We are willing to seek parties interested in working with as partners to develop, commercialize, and bring our novel therapeutics to patients around the world.
SystImmune Inc., has established three major technology platforms for the discovery and development of novel bio-therapeutics:
Antibody discovery: identification of monoclonal antibodies with unique characteristics through screening of thousands of target-specific IgG producing B cells using novel miniaturized immuno-assays
Multi-specific antibody engineering platforms
Process development platforms to manufacture our bio-therapeutics
PARTNERS
SystImmune Inc., has established three major technology platforms for the discovery and development of novel bio-therapeutics:
Antibody discovery: identification of monoclonal antibodies with unique characteristics through screening of thousands of target-specific IgG producing B cells using novel miniaturized immuno-assays
Multi-specific antibody engineering platforms
Process development platforms to manufacture our bio-therapeutics
PARTNERS
